Softwr

Healthcare · head to head

Lunit vs TherapyNotes

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
TherapyNotes logo

TherapyNotes

Healthcare

EHR and practice management for therapists

From
$39/month
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; TherapyNotes no API access, preventing integration with external systems
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, TherapyNotes covers Electronic Health Records.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and TherapyNotes actually diverge.

Attributes where Lunit and TherapyNotes differ
AttributeLunitTherapyNotes
Starting priceOn request$39/month
Pricing modelquotesubscription
FoundedUnknown2010

Identical on both: free tier (No), platforms (Web), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in TherapyNotes

  • Electronic Health Records
  • Scheduling
  • Billing
  • Patient Portal
  • Telehealth
  • Outcome Tracking
  • Clearinghouses
  • Insurance

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot TherapyNotes
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot TherapyNotes
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot TherapyNotes
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot TherapyNotes

TherapyNotes

  • Patient Carenot Lunit
  • Medical Recordsnot Lunit
  • Practice Managementnot Lunit
  • Telehealthnot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

TherapyNotes

  • No API access, preventing integration with external systems
  • Outdated interface compared to AI-driven competitors
  • No native mobile app for iOS or Android
  • No bulk actions to update multiple sessions at once

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

TherapyNotes

$39/month
  • Solo$39/month
    • Full EHR
    • Scheduling
    • Patient portal

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose TherapyNotes if

  • You need electronic health records.
  • You also want scheduling.
TherapyNotes review

Questions people ask

Is Lunit or TherapyNotes better?
Neither clearly leads. Lunit starts at On request and TherapyNotes at $39/month, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or TherapyNotes?
Lunit starts at On request and TherapyNotes at $39/month.
Does Lunit or TherapyNotes run on more platforms?
Both run on Web, so platform support will not decide this one for you.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what TherapyNotes is typically brought in for.
What can Lunit do that TherapyNotes cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. TherapyNotes covers Electronic Health Records, Scheduling, Billing, Patient Portal.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

TherapyNotes: Does TherapyNotes integrate with other applications?

TherapyNotes has zero API availability and cannot connect to external systems including marketing platforms, CRMs, or data dashboards. Unlike competitors, it lacks integration capabilities.

Source
Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

TherapyNotes: What are TherapyNotes pricing plans?

TherapyNotes charges $69/month for a solo practitioner plan and $79/month for the first clinician in a group with $50/month per additional clinician. A 30-day free trial is included with every plan.

Source
Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

TherapyNotes: Does TherapyNotes include telehealth?

Yes. TherapyNotes includes Basic Telehealth at no extra cost on every plan, with standard-definition video for up to 2 participants. Premium Telehealth with full HD, screen sharing, and closed captions costs $15 per clinician per month.

Source
Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

More on Lunit

More on TherapyNotes

Keep looking

Other head to heads